It was learned from Shuangyu District of Chengde City that the first phase of the first phase of the Beiqi Foton Auto Parts Foundry Center located in the provincial vanadium-titanium metallurgy industry cluster area has entered the mass production supply phase. About 200 boxes are produced every day, with a monthly production volume of 2,000 tons. This year, the output value can reach 37.8 million yuan.
It is understood that Beiqi Foton Automotive Parts Foundry Center is a key project in Hebei Province with a total investment of nearly 3.7 billion yuan. It mainly produces components for Mercedes-Benz heavy-duty engines, Foton Cummins Engines, Foton Aoling Engines, and Beijing Automotive Group's engine products. The project is constructed in three phases. The first phase of the investment is 1.995 billion yuan, covers an area of ​​468.6 acres, and produces 95,000 tons of automobile engine castings annually. At present, the first phase of the project has been officially operational, with an actual production capacity of 60,000 tons per year. The first-phase and second-phase construction of the project will also start. It is planned to build a new 35,000-ton engine casting production line on the north side of the new plant. By 2014, the engine casting production capacity will reach approximately 95,000 tons, which will satisfy the needs of Foton Group in the short term.
Influenza Vaccine, Live, Nasal, Freeze-dried Exclusively authorized by the WHO in China
Influenza Vaccine, Live, Nasal, Freeze-dried is a cooperative project with the WHO, which has been included in Global Action Plan for Influenza Vaccines (GAP)[1]. Hundreds of millions of doses have been used in the world, and Changchun BCHT Biotechnology Co. has the exclusive right of production and
operation in China.
Intranasal spray administration, no injection and no pain
The vaccine is inoculated by nasal spray, equipped with nasal spray device, and only needs to spray once a year in two nostrils to prevent influenza.
Mucosal immunity + Cellular immunity + Humoral immunity
After influenza virus attacks human body, it widely exists in nasal cavity, respiratory tract and other mucosal parts, as well as in body fluids and cells.
Vaccination of Influenza Vaccine, Live, Nasal, Freeze-dried can quickly stimulate the triple immune response of human body, and carry out defense
against viruses in different parts:
·Intranasal administration can produce mucosal immunity (IgA antibody), which forms the first immune defense line in the nasal cavity.
·Produce humoral immunity (IgG antibody) to remove influenza virus from body fluids.
·Produce cellular immunity (T cells) to remove influenza virus from cells
3+N More extensive protection
The production strains are recommended and supplied by the WHO every year.
The vaccine can not only effectively resist the vaccine strain, but also produce cross immunity to other subtypes of influenza virus.
Produced with SPF embryonated eggs
SPF
The chick embryos for vaccine production comes from SPF (specific pathogen free) chicken flocks, so the risk of exogenous pathogenic microorganism
pollution is excluded.
Free of inactivator, split agent and preservative
Influenza Vaccine Live Manufactured,Influenza Vaccines In Vial,Flu Vaccine In Vial,Influenza Vaccine While Having Flu
Changchun BCHT Biotechnology Co. , https://www.ccbcht.net